{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:13:17Z","timestamp":1788786797753,"version":"build-2803163510"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The clinical occurrence of primary hyperthyroidism (PH) combined with primary hyperparathyroidism (PHPT) is exceedingly rare. There remains considerable debate regarding the necessity of iodine use prior to surgery for hyperthyroidism and whether thyroid function should be normalized before proceeding with the operation. Furthermore, the decision on whether to perform total parathyroidectomy or subtotal parathyroidectomy due to parathyroid hyperplasia must be based on a comprehensive assessment by a multidisciplinary team (MDT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>Herein, we report a rare case of concurrent PH, caused by Graves\u2019 disease(GD), and PHPT. Through the collaboration of a MDT, we developed a personalized preoperative preparation and surgical plan for the patient, successfully managing the postoperative complications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Clinicians should maintain a high level of suspicion for PHPT in hyperthyroid patients with hypercalcemia. Additionally, the decision regarding the preoperative use of iodine, the normalization of thyroid function before surgery, and the surgical approach to parathyroid hyperplasia should be determined through effective preoperative assessment, imaging studies, and MDT collaboration. This strategy allows for the formulation of individualized treatment plans, mitigating the risks of postoperative hyperthyroid crises, recurrence of PHPT, and permanent parathyroid insufficiency.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1524367","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T05:47:39Z","timestamp":1743140859000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Primary hyperthyroidism complicated by primary hyperparathyroidism: a case report and literature review"],"prefix":"10.3389","volume":"15","author":[{"given":"Hongpeng","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghe","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(03)14073-1","article-title":"Hyperthyroidism","volume":"362","author":"Cooper","year":"2003","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0801880","article-title":"Clinical practice. Graves\u2019 disease","volume":"358","author":"Brent","year":"2008","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/nejm200010263431707","article-title":"Graves\u2019 disease","volume":"343","author":"Weetman","year":"2000","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12196321","article-title":"Primary hyperparathyroidism in older adults: A narrative review of the most recent literature on epidemiology, diagnosis and management","volume":"12","author":"Rizk","year":"2023","journal-title":"J Clin Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2291","article-title":"Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review","volume":"94","author":"Golden","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40520-016-0666-7","article-title":"Parathyroidectomy for primary hyperparathyroidism in the elderly: experience of a single endocrine surgery center","volume":"29","author":"Cal\u00f2","year":"2017","journal-title":"Aging Clin Exp Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.beem.2018.09.001","article-title":"Classical complications of primary hyperparathyroidism","volume":"32","author":"Minisola","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2286-6","article-title":"Management of patients with primary hyperparathyroidism and concurrent thyroid disease: an evolving field","volume":"19","author":"Spanheimer","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12902-022-01117-0","article-title":"Case report: coexistence of primary hyperparathyroidism with giant toxic nodular goiter","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1212138","article-title":"Prevalence of primary hyperparathyroidism in 13387 patients with thyroid diseases, newly diagnosed by screening of serum calcium","volume":"107","author":"Wagner","year":"1999","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2182539","article-title":"Surgical approach to primary hyperparathyroidism in patients with concomitant thyroid diseases: A retrospective single center study","volume":"2020","author":"Castellano","year":"2020","journal-title":"Int J Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/hed.20366","article-title":"Prevalence and risk factors for primary hyperparathyroidism in hyperthyroid patients","volume":"28","author":"Abboud","year":"2006","journal-title":"Head Neck"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.16802","article-title":"Hyperthyroidism caused by massive toxic nodular goiter accompanied by primary hyperparathyroidism","volume":"134","author":"Musia\u0142kiewicz","year":"2024","journal-title":"Pol Arch Intern Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-203436","article-title":"Incidental finding of papillary thyroid carcinoma with BRAFV600E mutation in a patient with coexistent primary hyperparathyroidism and Graves\u2019 hyperthyroidism","volume":"2014","author":"He","year":"2014","journal-title":"BMJ Case Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.54.2605","article-title":"Hypercalcemic crisis due to primary hyperparathyroidism occurring concomitantly with Graves\u2019 disease","volume":"54","author":"Yokomoto","year":"2015","journal-title":"Intern Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/2050313x211059002","article-title":"A case of Turner\u2019s syndrome with Graves\u2019 disease and primary hyperparathyroidism","volume":"9","author":"Nagaki","year":"2021","journal-title":"SAGE Open Med Case Rep"},{"key":"B17","article-title":"Concomitant Graves\u2019 disease and primary hyperparathyroidism: the first case report in mainland of China and literature review","volume":"115","author":"Xiao","year":"2002","journal-title":"Chin Med J (Engl)"},{"key":"B18","first-page":"199","article-title":"Concomitant primary hyperparathyroidism, Graves\u2019 disease and vitamin D deficiency","volume":"23","author":"Miani","year":"2003","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.51.7102","article-title":"Severe hypocalcemia complicated by postsurgical hypoparathyroidism and hungry bone syndrome in a patient with primary hyperparathyroidism, Graves\u2019 disease, and acromegaly","volume":"51","author":"Tachibana","year":"2012","journal-title":"Intern Med"},{"key":"B20","article-title":"Papillary parathyroid adenoma. A rare occurrence and its importance in differentiation from papillary carcinoma of the thyroid","volume":"120","author":"Ho","year":"1996","journal-title":"Arch Pathol Lab Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/bf00192107","article-title":"Multiple endocrine neoplasia type 1 (MEN 1) revisited","volume":"426","author":"Padberg","year":"1995","journal-title":"Virchows Arch"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4158\/ep.9.6.517","article-title":"Hypercalcemia in hyperthyroidism: patterns of serum calcium, parathyroid hormone, and 1,25-dihydroxyvitamin D3 levels during management of thyrotoxicosis","volume":"9","author":"Iqbal","year":"2003","journal-title":"Endocr Pract"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1159\/000450976","article-title":"Pre-operative Lugol\u2019s iodine treatment in the management of patients undergoing thyroidectomy for Graves\u2019 Disease: A review of the literature","volume":"6","author":"Hope","year":"2017","journal-title":"Eur Thyroid J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1177\/0194599819829052","article-title":"Effects of preoperative iodine administration on thyroidectomy for hyperthyroidism: A systematic review and meta-analysis","volume":"160","author":"Tsai","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3126-z","article-title":"Is potassium iodide solution necessary before total thyroidectomy for Graves disease","volume":"20","author":"Shinall","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-008-9076-8","article-title":"Is rapid preparation for thyroidectomy in severe Graves\u2019 disease beneficial? The relationship between clinical and immunohistochemical aspects","volume":"33","author":"Hassan","year":"2008","journal-title":"Endocrine"},{"key":"B28","article-title":"Effect of preoperative iodine in patients with Graves\u2019 disease controlled with antithyroid drugs and thyroxine","volume":"70","author":"Kaur","year":"1988","journal-title":"Ann R Coll Surg Engl"},{"key":"B29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1089\/thy.2017.0243","article-title":"Thyroid storm: A Japanese perspective","volume":"28","author":"Akamizu","year":"2018","journal-title":"Thyroid"},{"key":"B30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40463-018-0281-z","article-title":"A retrospective cohort study: do patients with graves\u2019 disease need to be euthyroid prior to surgery","volume":"47","author":"Al Jassim","year":"2018","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of the 2022 WHO classification of parathyroid tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocr Pathol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11071967","article-title":"Management and long-term follow-up of hyperparathyroidism in multiple endocrine neoplasia type 1: single center experience","volume":"11","author":"Yavropoulou","year":"2022","journal-title":"J Clin Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.853171","article-title":"Germline mutations related to primary hyperparathyroidism identified by next-generation sequencing","volume":"13","author":"Park","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.876692","article-title":"Severe secondary hyperparathyroidism in a chronic kidney disease patient treated with Radiofrequency ablation: One case report","volume":"9","author":"Muhetaer","year":"2022","journal-title":"Front Med (Lausanne)"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1524367\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T05:47:59Z","timestamp":1743140879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1524367\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":34,"alternative-id":["10.3389\/fonc.2025.1524367"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1524367","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"article-number":"1524367"}}